Diabetes (type 1 and type 2) in children and young people: diagnosis and management (NG18)Product type:GuidanceProgramme:NICE guidelineLast updated: 31 March 2022Published: 1 August 2015
Type 1 diabetes in adults: diagnosis and management (NG17)Product type:GuidanceProgramme:NICE guidelineLast updated: 31 March 2022Published: 26 August 2015
Type 2 diabetes in adults: management (NG28)Product type:GuidanceProgramme:NICE guidelineLast updated: 31 March 2022Published: 2 December 2015
3C Patch for treating diabetic foot ulcers (MTG66)Product type:GuidanceProgramme:Medical technologies guidancePublished: 7 March 2022
Diabetes in pregnancy: management from preconception to the postnatal period (NG3)Product type:GuidanceProgramme:NICE guidelineLast updated: 16 December 2020Published: 25 February 2015
Ranibizumab for treating diabetic retinopathy (terminated appraisal) (TA637)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 30 June 2020
Sotagliflozin with insulin for treating type 1 diabetes (TA622)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 12 February 2020
Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema in phakic eyes after an inadequate response to previous therapy (TA613)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 20 November 2019
Diabetic foot problems: prevention and management (NG19)Product type:GuidanceProgramme:NICE guidelineLast updated: 11 October 2019Published: 26 August 2015
Ertugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetes (TA583)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 5 June 2019
Ertugliflozin as monotherapy or with metformin for treating type 2 diabetes (TA572)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 27 March 2019
The Debrisoft monofilament debridement pad for use in acute or chronic wounds (MTG17)Product type:GuidanceProgramme:Medical technologies guidanceLast updated: 25 March 2019Published: 25 March 2014
Neuropad for detecting preclinical diabetic peripheral neuropathy (MTG38)Product type:GuidanceProgramme:Medical technologies guidancePublished: 10 September 2018
Type 2 diabetes: prevention in people at high risk (PH38)Product type:GuidanceProgramme:Public health guidelineLast updated: 15 September 2017Published: 12 July 2012
Dapagliflozin in combination therapy for treating type 2 diabetes (TA288)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 23 November 2016Published: 26 June 2013
Dapagliflozin in triple therapy for treating type 2 diabetes (TA418)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 23 November 2016
Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes (TA390)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 May 2016
Integrated sensor-augmented pump therapy systems for managing blood glucose levels in type 1 diabetes (the MiniMed Paradigm Veo system and the Vibe and G4 PLATINUM CGM system) (DG21)Product type:GuidanceProgramme:Diagnostics guidancePublished: 12 February 2016
Aflibercept for treating diabetic macular oedema (TA346)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 22 July 2015
Dexamethasone intravitreal implant for treating diabetic macular oedema (TA349)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 22 July 2015
Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetes (IPG518)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 27 March 2015
Empagliflozin in combination therapy for treating type 2 diabetes (TA336)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 March 2015
VibraTip for testing vibration perception to detect diabetic peripheral neuropathy (MTG22)Product type:GuidanceProgramme:Medical technologies guidanceLast updated: 1 March 2015Published: 31 December 2014
Canagliflozin in combination therapy for treating type 2 diabetes (TA315)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 June 2014
Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after an inadequate response to prior therapy (TA301)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 27 November 2013
Ranibizumab for treating diabetic macular oedema (TA274)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 27 February 2013
Type 2 diabetes prevention: population and community-level interventions (PH35)Product type:GuidanceProgramme:Public health guidelinePublished: 10 May 2011
Autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy (IPG274)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 24 September 2008
Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (TA151)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 23 July 2008
Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus (IPG257)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 April 2008
d-Nav insulin management app for type 2 diabetes (MIB285)Product type:AdviceProgramme:Medtech innovation briefingPublished: 8 February 2022
AI technologies for detecting diabetic retinopathy (MIB265)Product type:AdviceProgramme:Medtech innovation briefingPublished: 6 July 2021
Dexcom G6 for real-time continuous glucose monitoring (MIB233)Product type:AdviceProgramme:Medtech innovation briefingPublished: 3 November 2020
t:slim X2 insulin pump for managing blood glucose levels in type 1 diabetes (MIB227)Product type:AdviceProgramme:Medtech innovation briefingPublished: 22 September 2020
Noctura 400 Sleep Mask for diabetic retinopathy and diabetic macular oedema (MIB144)Product type:AdviceProgramme:Medtech innovation briefingPublished: 24 April 2018
Health app: GDm-Health for people with gestational diabetes (MIB131)Product type:AdviceProgramme:Medtech innovation briefingPublished: 13 November 2017
FreeStyle Libre for glucose monitoring (MIB110)Product type:AdviceProgramme:Medtech innovation briefingLast updated: 29 September 2017Published: 3 July 2017
Aptiva for painful diabetic neuropathy (MIB119)Product type:AdviceProgramme:Medtech innovation briefingPublished: 13 September 2017
MiniMed 640G system with SmartGuard for managing blood glucose levels in people with type 1 diabetes (MIB51)Product type:AdviceProgramme:Medtech innovation briefingPublished: 12 February 2016
Diabetes mellitus type 1 and type 2: insulin glargine biosimilar (Abasaglar) (ESNM64)Product type:AdviceProgramme:Evidence summaryPublished: 2 December 2015
Type 2 diabetes mellitus in adults: high-strength insulin glargine 300 units/ml (Toujeo) (ESNM65)Product type:AdviceProgramme:Evidence summaryPublished: 2 December 2015
Type 1 diabetes mellitus in adults: high-strength insulin glargine 300 units/ml (Toujeo) (ESNM62)Product type:AdviceProgramme:Evidence summaryPublished: 13 October 2015
Type 2 diabetes: insulin degludec/liraglutide (Xultophy) (ESNM60)Product type:AdviceProgramme:Evidence summaryPublished: 3 July 2015
Type 2 diabetes: dulaglutide (ESNM59)Product type:AdviceProgramme:Evidence summaryPublished: 16 June 2015
Type 2 diabetes: insulin degludec (ESNM25)Product type:AdviceProgramme:Evidence summaryPublished: 10 September 2013
Diabetes in children and young people (QS125)Product type:Quality standardLast updated: 31 March 2022Published: 14 July 2016
Promoting health and preventing premature mortality in black, Asian and other minority ethnic groups (QS167)Product type:Quality standardPublished: 11 May 2018
Diabetes in adults (QS6)Product type:Quality standardLast updated: 18 August 2016Published: 30 March 2011
Diabetes (type 1 and type 2) in children and young people: diagnosis and management – periodontal diseaseStatus:In developmentProgramme:NICE guidelineExpected publication date: 29 June 2022
Type 1 diabetes in adults: diagnosis and management – periodontal diseaseStatus:In developmentProgramme:NICE guidelineExpected publication date: 29 June 2022
Type 2 diabetes in adults: management - periodontal diseaseStatus:In developmentProgramme:NICE guidelineExpected publication date: 29 June 2022
Finerenone for treating chronic kidney disease in people with type 2 diabetes [ID3773]Status:In development | In consultationProgramme:Technology appraisal guidanceConsultation end date: 6 June 2022Expected publication date: 14 September 2022
Dexamethasone intravitreal implant for treating diabetic macular oedema in people without a pseudophakic lens [ID3951]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: 14 September 2022
Brolucizumab for treating diabetic macular oedema [ID3902]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 16 November 2022
Diabetic foot problems: prevention and management (update)Status:In developmentProgramme:NICE guidelineExpected publication date: 18 January 2023
Diabetes (type 1 and type 2) in children and young people: diagnosis and management - medicines for type 2 diabetes (update)Status:In developmentProgramme:NICE guidelineExpected publication date: 3 January 2024
Diabetic retinopathyStatus:In developmentProgramme:NICE guidelineExpected publication date: 3 April 2024
Diabetic retinopathy - ruboxistaurin [ID382]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Macular oedema (diabetic) - pegaptanib sodium [ID452]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Diabetes - buccal insulin [ID311]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Empagliflozin for reducing the risk of cardiovascular events in type 2 diabetes [ID1037]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Empagliflozin for type 1 Diabetes Mellitus, adjunct to insulin ID1275Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Ticagrelor for preventing cardiovascular events in people with type 2 diabetes and coronary artery disease [ID1514]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Semaglutide for treating type 2 diabetes (ID1450)Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Dulaglutide for treating type 2 diabetes [ID1451]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Canagliflozin for treating chronic kidney disease in people with type 2 diabetes [ID1653]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Sotagliflozin for treating type 2 diabetes [ID1657]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Faricimab for treating diabetic macular oedema [ID3899]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Tirzepatide for treating type 2 diabetes ID3938Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Hybrid closed loop systems for managing blood glucose levels in type 1 diabetesStatus:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Teplizumab for delaying the onset of type 1 diabetes in people 8 years and over at risk of developing the condition TS ID 10753Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Type 2 diabetes in adults: management (medicines update)Status:In developmentProgramme:NICE guidelineExpected publication date: TBC
Community based approaches to addressing high blood pressure with black African and Caribbean menProduct type:Shared learningPublished: 13 August 2021
Help to Care Mobile App: Supporting care workers and carers to identify and prevent deteriorationProduct type:Shared learningPublished: 9 September 2020
Ambulatory Acute Foot Service - Royal Free London NHS FTProduct type:Shared learningPublished: 20 January 2020
Tackling the overtreatment of type 2 diabetes in frail older people through individualising care in East Sussex: a pharmacist led projectProduct type:Shared learningPublished: 17 September 2019
Development of Black and minority ethnic (BME) patient-centred dietary resources to improve hyperkalaemia in chronic kidney disease patientsProduct type:Shared learningPublished: 28 March 2019
Improving foot care outcomes for people with diabetes in WessexProduct type:Shared learningPublished: 22 March 2019
Turning the tide on ineffective prescribing of glucagon like peptide (GLP-1) mimetics in type 2 diabetes in East SussexProduct type:Shared learningPublished: 29 November 2018
A language specific and culturally adapted pain management programmeProduct type:Shared learningPublished: 14 May 2018
Young Adult Diabetes: Engaging to improve; outcomes of the young adult clinic restructureProduct type:Shared learningPublished: 3 April 2018
Supporting the management of type 2 diabetes with pharmacist-led reviews and implementing NICE recommended nine key care processesProduct type:Shared learningPublished: 12 February 2018
NICE Fellowship project to facilitate the implementation of NICE guidance PH38 via the utilisation of Tier 2 and Tier 3 weight management and lifestyle-intervention programmes for the prevention of type 2 diabetesProduct type:Shared learningPublished: 14 November 2017
Implementing an active foot disease pathway for people with diabetes in South TeesProduct type:Shared learningPublished: 1 July 2016
Implementing multiple daily injection insulin regimens (MDI) with carbohydrate counting for children and young people at diagnosis of type 1 diabetes: education provided by the Children’s Diabetes Service for patients, families and staffProduct type:Shared learningPublished: 6 April 2016
Training non-podiatrists to assess foot risk as part of an integrated foot service for people with diabetesProduct type:Shared learningPublished: 16 February 2016
PITstop training and the use of NICE guidance and the Type 2 diabetes treatment pathwayProduct type:Shared learningPublished: 29 July 2014
Establishing a Multi-disciplinary Diabetes Stakeholder Network: Early resultsProduct type:Shared learningPublished: 20 June 2014
Using a Quality Improvement Framework to make local population health gainsProduct type:Shared learningPublished: 30 November 2012
An innovative approach to providing lifestyle education and behaviour change to prevent type 2 diabetesProduct type:Shared learningPublished: 26 June 2012
Walking Away from Type 2 Diabetes: implementation of a diabetes prevention programmeProduct type:Shared learningPublished: 1 June 2012
Establishing a children's insulin pump service in LeedsProduct type:Shared learningPublished: 10 February 2009